Genetics Navigator: a digital platform to guide people through genetic testing
Official title: The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services
Run by Unity Health Toronto · NCT06455384 · Data updated 2026-11-12
This randomized trial will test whether the Genetics Navigator digital platform helps adults and parents of children referred for clinical genetic testing have less distress and a smoother testing process compared with usual genetics appointments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | Unity Health Toronto Academic / other |
| Locations | 3 sites (Toronto, Ontario and 2 other locations) |
| Status | Recruiting |
| Started | October 28, 2025 |
| Main results expected | March 2027 |
| Study ends | July 2027 |
| Registry record updated | June 24, 2026 |
| Trial ID | NCT06455384 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults referred for clinical genetic testing and parents or legal guardians of pediatric patients referred to participating clinicians at Mount Sinai Hospital, SickKids, or Sunnybrook in Toronto who are fluent in English and eligible for testing are ideal candidates.
✕Probably not a fit
Patients who need urgent or prenatal genetic testing, those not eligible for clinical genetic testing in Ontario, or those not fluent in English are unlikely to benefit from this platform-based pathway.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled trial enrolling adults and parents of pediatric patients referred for clinical genetic testing at three Toronto hospitals. Participants are randomized to use the Genetics Navigator, an end-to-end e-health platform that provides education, a decision aid, family/history collection, and results delivery, or to standard care with genetics professionals. The study measures patient distress, decision quality, patient experience, and service efficiency. Results will determine whether the platform can substitute for or augment traditional genetics appointments.
Why it matters
Potential benefit: If successful, the Genetics Navigator could reduce waiting-related distress, improve patient understanding and decision making, and streamline delivery of genetic testing services.
How similar studies have gone: The team previously tested a related decision support tool (Genetics ADvISER) with promising results, but the Genetics Navigator is a broader end-to-end platform being tested in a randomized trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion: * Adult patients (18 years of age or older) who are referred to participating clinicians at Mount Sinai Hospital for clinical genetic testing. * Parents/legal guardians (18 years of age or older) of pediatric patients who are referred to participating clinicians at SickKids for clinical genetic testing. Exclusion: * Known not to be eligible for clinical genetic testing in Ontario * Requires urgent clinical genetic testing or prenatal genetic testing * Not fluent in English (speaking and reading)
Where it's running
-
Mount Sinai Hospital
Toronto, Ontario, Canada Recruiting -
The Hospital for Sick Children
Toronto, Ontario, Canada Recruiting -
Sunnybrook Hospital
Toronto, Canada Recruiting
Study contacts
- Principal investigator: Yvonne Bombard, PhD — St. Michael's Hospital and University of Toronto
- Study coordinator: Marc Clausen, MA
- Email: Marc.Clausen@unityhealth.to
- Phone: 416-864-6060
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Melillo Method for kids with behavior and learning challenges
This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.
-
Sleep and Music for Kids with Epilepsy
This trial tests if a music-based program can improve sleep and health for children with epilepsy and their parents.
-
Multimodal Eye Data Bank to Explore Inflammation-Related Eye Diseases
This observational effort collects rich eye-imaging data from people with inflammatory and retinal conditions to see how the front and back of the eye relate and to build a standardized database that could support future AI tools.
-
Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders
This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.